课题基金 / 基金详情

项目摘要

项目成果

SANFORD M SIMON的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY Fibrolamellar hepatocellular carcinoma (FLHCC) is an often-lethal disease affecting primarily children and young adults. The poor prognosis stems from both the lack of sensitive non-invasive diagnostic tests and the lack of a targeted systemic therapy. We have recently demonstrated a single, consistent deletion in one copy of chromosome 19 of FLHCC patients that results in a chimeric gene. This encodes a chimeric protein comprised of the amino terminal portion of the heat shock protein DNAJB1 fused to the active catalytic subunit of protein kinase A. This project will determine if this chimera is sufficient for transforming cells. It will then determine the extent of cellular changes upon induction of the chimera and begin to elucidate the pathways and mechanisms for these changes.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the oncoprotein that drives FLC
  • 批准号:
    10902751
  • 项目类别:
  • 资助金额:
    $18.88万
  • 财政年份:
    2023
  • 负责人:
    SANFORD M SIMON
  • 依托单位:
Center for therapeutic targeting of the Fusion Oncoprotein of Fibrolamellar Hepatocellular Carcinoma
  • 批准号:
    10826323
  • 项目类别:
  • 资助金额:
    $18.88万
  • 财政年份:
    2023
  • 负责人:
    SANFORD M SIMON
  • 依托单位:
ASO and shRNA for targeting the oncogenic transcript driving fibrolamellar hepatocellular carcinoma
  • 批准号:
    10652432
  • 项目类别:
  • 资助金额:
    $41.58万
  • 财政年份:
    2020
  • 负责人:
    SANFORD M SIMON
  • 依托单位:
ASO and shRNA for targeting the oncogenic transcript driving fibrolamellar hepatocellular carcinoma
  • 批准号:
    10171814
  • 项目类别:
  • 资助金额:
    $42.43万
  • 财政年份:
    2020
  • 负责人:
    SANFORD M SIMON
  • 依托单位:
海外基金